MAPT and Alzheimer disease: In the current study, it was also demonstrated that EVs can mitigate pathological phenotypes and alleviate AD pathology in DS-derived CS, including reduction in cell death, decrease in p-tau levels, and alleviation of Aβ40 and Aβ42 depositions.